Isabel Ortuño‐Lizarán

Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity

Isabel Ortuño‐Lizarán, Thomas G. Beach, Geidy E. Serrano et al. · Movement Disorders · 2018 · 159 citations

Neurochemical Biomarkers, Social Sciences, Neurobiology Of Disease +18

Cellular Characterization of OCT and Outer Retinal Bands Using Specific Immunohistochemistry Markers and Clinical Implications

Nicolás Cuenca, Isabel Ortuño‐Lizarán, Isabel Pinilla · Ophthalmology · 2017 · 127 citations

Clinical Implications, Retina, Ocular Disease +6

Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease

Isabel Ortuño‐Lizarán, Xavier Sánchez‐Sáez, Pedro Lax et al. · Annals of Neurology · 2020 · 105 citations · Full text

Metal–Organic Frameworks as Drug Delivery Platforms for Ocular Therapeutics

Jesús Gándara-Loe, Isabel Ortuño‐Lizarán, Laura Fernández‐Sánchez et al. · ACS Applied Materials & Interfaces · 2018 · 95 citations · Full text

Single-cell ATAC-seq of fetal human retina and stem-cell-derived retinal organoids shows changing chromatin landscapes during cell fate acquisition

Connor Finkbeiner, Isabel Ortuño‐Lizarán, Akshayalakshmi Sridhar et al. · Cell Reports · 2022 · 88 citations · Full text

Single-cell Atac-seq, Transcriptomics Technology, Accessible Chromatin +26